# 逐題詳解 [上一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/77/) 第 78 / 180 [下一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/79/) 全部36000題詳解已提供中英顯示、基本符號及結構檢查，且第1–36000題已全部完成第二對話數理與中英語義覆核；不再有顯示／符號檢查候選。 候選群共 36000 題；已發布 36000 題詳解，其中數理覆核 36000 題、顯示／符號檢查候選 0 題；其餘 0 題尚未在此發布。 - [第 15401 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0001/) · R0029-15401 · 已數理覆核 - [第 15402 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0002/) · R0029-15402 · 已數理覆核 - [第 15403 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0003/) · R0029-15403 · 已數理覆核 - [第 15404 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0004/) · R0029-15404 · 已數理覆核 - [第 15405 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0005/) · R0029-15405 · 已數理覆核 - [第 15406 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0006/) · R0029-15406 · 已數理覆核 - [第 15407 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0007/) · R0029-15407 · 已數理覆核 - [第 15408 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0008/) · R0029-15408 · 已數理覆核 - [第 15409 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0009/) · R0029-15409 · 已數理覆核 - [第 15410 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0010/) · R0029-15410 · 已數理覆核 - [第 15411 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0011/) · R0029-15411 · 已數理覆核 - [第 15412 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0012/) · R0029-15412 · 已數理覆核 - [第 15413 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0013/) · R0029-15413 · 已數理覆核 - [第 15414 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0014/) · R0029-15414 · 已數理覆核 - [第 15415 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0015/) · R0029-15415 · 已數理覆核 - [第 15416 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0016/) · R0029-15416 · 已數理覆核 - [第 15417 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0017/) · R0029-15417 · 已數理覆核 - [第 15418 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0018/) · R0029-15418 · 已數理覆核 - [第 15419 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0019/) · R0029-15419 · 已數理覆核 - [第 15420 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0020/) · R0029-15420 · 已數理覆核 - [第 15421 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0021/) · R0029-15421 · 已數理覆核 - [第 15422 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0022/) · R0029-15422 · 已數理覆核 - [第 15423 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0023/) · R0029-15423 · 已數理覆核 - [第 15424 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0024/) · R0029-15424 · 已數理覆核 - [第 15425 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0025/) · R0029-15425 · 已數理覆核 - [第 15426 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0051/) · R0029-15426 · 已數理覆核 - [第 15427 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0052/) · R0029-15427 · 已數理覆核 - [第 15428 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0053/) · R0029-15428 · 已數理覆核 - [第 15429 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0054/) · R0029-15429 · 已數理覆核 - [第 15430 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0055/) · R0029-15430 · 已數理覆核 - [第 15431 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0056/) · R0029-15431 · 已數理覆核 - [第 15432 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0057/) · R0029-15432 · 已數理覆核 - [第 15433 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0058/) · R0029-15433 · 已數理覆核 - [第 15434 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0059/) · R0029-15434 · 已數理覆核 - [第 15435 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0060/) · R0029-15435 · 已數理覆核 - [第 15436 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0061/) · R0029-15436 · 已數理覆核 - [第 15437 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0062/) · R0029-15437 · 已數理覆核 - [第 15438 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0063/) · R0029-15438 · 已數理覆核 - [第 15439 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0064/) · R0029-15439 · 已數理覆核 - [第 15440 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0065/) · R0029-15440 · 已數理覆核 - [第 15441 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0066/) · R0029-15441 · 已數理覆核 - [第 15442 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0067/) · R0029-15442 · 已數理覆核 - [第 15443 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0068/) · R0029-15443 · 已數理覆核 - [第 15444 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0069/) · R0029-15444 · 已數理覆核 - [第 15445 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0070/) · R0029-15445 · 已數理覆核 - [第 15446 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0071/) · R0029-15446 · 已數理覆核 - [第 15447 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0072/) · R0029-15447 · 已數理覆核 - [第 15448 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0073/) · R0029-15448 · 已數理覆核 - [第 15449 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0074/) · R0029-15449 · 已數理覆核 - [第 15450 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0075/) · R0029-15450 · 已數理覆核 - [第 15451 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0026/) · R0029-15451 · 已數理覆核 - [第 15452 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0027/) · R0029-15452 · 已數理覆核 - [第 15453 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0028/) · R0029-15453 · 已數理覆核 - [第 15454 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0029/) · R0029-15454 · 已數理覆核 - [第 15455 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0030/) · R0029-15455 · 已數理覆核 - [第 15456 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0031/) · R0029-15456 · 已數理覆核 - [第 15457 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0032/) · R0029-15457 · 已數理覆核 - [第 15458 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0033/) · R0029-15458 · 已數理覆核 - [第 15459 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0034/) · R0029-15459 · 已數理覆核 - [第 15460 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0035/) · R0029-15460 · 已數理覆核 - [第 15461 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0036/) · R0029-15461 · 已數理覆核 - [第 15462 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0037/) · R0029-15462 · 已數理覆核 - [第 15463 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0038/) · R0029-15463 · 已數理覆核 - [第 15464 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0039/) · R0029-15464 · 已數理覆核 - [第 15465 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0040/) · R0029-15465 · 已數理覆核 - [第 15466 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0041/) · R0029-15466 · 已數理覆核 - [第 15467 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0042/) · R0029-15467 · 已數理覆核 - [第 15468 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0043/) · R0029-15468 · 已數理覆核 - [第 15469 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0044/) · R0029-15469 · 已數理覆核 - [第 15470 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0045/) · R0029-15470 · 已數理覆核 - [第 15471 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0046/) · R0029-15471 · 已數理覆核 - [第 15472 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0047/) · R0029-15472 · 已數理覆核 - [第 15473 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0048/) · R0029-15473 · 已數理覆核 - [第 15474 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0049/) · R0029-15474 · 已數理覆核 - [第 15475 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0050/) · R0029-15475 · 已數理覆核 - [第 15476 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0076/) · R0029-15476 · 已數理覆核 - [第 15477 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0077/) · R0029-15477 · 已數理覆核 - [第 15478 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0078/) · R0029-15478 · 已數理覆核 - [第 15479 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0079/) · R0029-15479 · 已數理覆核 - [第 15480 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0080/) · R0029-15480 · 已數理覆核 - [第 15481 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0081/) · R0029-15481 · 已數理覆核 - [第 15482 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0082/) · R0029-15482 · 已數理覆核 - [第 15483 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0083/) · R0029-15483 · 已數理覆核 - [第 15484 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0084/) · R0029-15484 · 已數理覆核 - [第 15485 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0085/) · R0029-15485 · 已數理覆核 - [第 15486 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0086/) · R0029-15486 · 已數理覆核 - [第 15487 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0087/) · R0029-15487 · 已數理覆核 - [第 15488 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0088/) · R0029-15488 · 已數理覆核 - [第 15489 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0089/) · R0029-15489 · 已數理覆核 - [第 15490 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0090/) · R0029-15490 · 已數理覆核 - [第 15491 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0091/) · R0029-15491 · 已數理覆核 - [第 15492 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0092/) · R0029-15492 · 已數理覆核 - [第 15493 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0093/) · R0029-15493 · 已數理覆核 - [第 15494 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0094/) · R0029-15494 · 已數理覆核 - [第 15495 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0095/) · R0029-15495 · 已數理覆核 - [第 15496 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0096/) · R0029-15496 · 已數理覆核 - [第 15497 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0097/) · R0029-15497 · 已數理覆核 - [第 15498 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0098/) · R0029-15498 · 已數理覆核 - [第 15499 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0099/) · R0029-15499 · 已數理覆核 - [第 15500 題：商集](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261030-r04-quotient-set-0100/) · R0029-15500 · 已數理覆核 - [第 15501 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0026/) · R0030-15501 · 已數理覆核 - [第 15502 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0027/) · R0030-15502 · 已數理覆核 - [第 15503 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0028/) · R0030-15503 · 已數理覆核 - [第 15504 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0029/) · R0030-15504 · 已數理覆核 - [第 15505 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0030/) · R0030-15505 · 已數理覆核 - [第 15506 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0031/) · R0030-15506 · 已數理覆核 - [第 15507 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0032/) · R0030-15507 · 已數理覆核 - [第 15508 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0033/) · R0030-15508 · 已數理覆核 - [第 15509 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0034/) · R0030-15509 · 已數理覆核 - [第 15510 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0035/) · R0030-15510 · 已數理覆核 - [第 15511 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0036/) · R0030-15511 · 已數理覆核 - [第 15512 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0037/) · R0030-15512 · 已數理覆核 - [第 15513 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0038/) · R0030-15513 · 已數理覆核 - [第 15514 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0039/) · R0030-15514 · 已數理覆核 - [第 15515 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0040/) · R0030-15515 · 已數理覆核 - [第 15516 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0041/) · R0030-15516 · 已數理覆核 - [第 15517 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0042/) · R0030-15517 · 已數理覆核 - [第 15518 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0043/) · R0030-15518 · 已數理覆核 - [第 15519 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0044/) · R0030-15519 · 已數理覆核 - [第 15520 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0045/) · R0030-15520 · 已數理覆核 - [第 15521 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0046/) · R0030-15521 · 已數理覆核 - [第 15522 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0047/) · R0030-15522 · 已數理覆核 - [第 15523 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0048/) · R0030-15523 · 已數理覆核 - [第 15524 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0049/) · R0030-15524 · 已數理覆核 - [第 15525 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0050/) · R0030-15525 · 已數理覆核 - [第 15526 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0076/) · R0030-15526 · 已數理覆核 - [第 15527 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0077/) · R0030-15527 · 已數理覆核 - [第 15528 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0078/) · R0030-15528 · 已數理覆核 - [第 15529 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0079/) · R0030-15529 · 已數理覆核 - [第 15530 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0080/) · R0030-15530 · 已數理覆核 - [第 15531 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0081/) · R0030-15531 · 已數理覆核 - [第 15532 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0082/) · R0030-15532 · 已數理覆核 - [第 15533 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0083/) · R0030-15533 · 已數理覆核 - [第 15534 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0084/) · R0030-15534 · 已數理覆核 - [第 15535 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0085/) · R0030-15535 · 已數理覆核 - [第 15536 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0086/) · R0030-15536 · 已數理覆核 - [第 15537 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0087/) · R0030-15537 · 已數理覆核 - [第 15538 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0088/) · R0030-15538 · 已數理覆核 - [第 15539 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0089/) · R0030-15539 · 已數理覆核 - [第 15540 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0090/) · R0030-15540 · 已數理覆核 - [第 15541 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0091/) · R0030-15541 · 已數理覆核 - [第 15542 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0092/) · R0030-15542 · 已數理覆核 - [第 15543 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0093/) · R0030-15543 · 已數理覆核 - [第 15544 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0094/) · R0030-15544 · 已數理覆核 - [第 15545 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0095/) · R0030-15545 · 已數理覆核 - [第 15546 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0096/) · R0030-15546 · 已數理覆核 - [第 15547 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0097/) · R0030-15547 · 已數理覆核 - [第 15548 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0098/) · R0030-15548 · 已數理覆核 - [第 15549 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0099/) · R0030-15549 · 已數理覆核 - [第 15550 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0100/) · R0030-15550 · 已數理覆核 - [第 15551 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0051/) · R0030-15551 · 已數理覆核 - [第 15552 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0052/) · R0030-15552 · 已數理覆核 - [第 15553 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0053/) · R0030-15553 · 已數理覆核 - [第 15554 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0054/) · R0030-15554 · 已數理覆核 - [第 15555 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0055/) · R0030-15555 · 已數理覆核 - [第 15556 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0056/) · R0030-15556 · 已數理覆核 - [第 15557 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0057/) · R0030-15557 · 已數理覆核 - [第 15558 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0058/) · R0030-15558 · 已數理覆核 - [第 15559 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0059/) · R0030-15559 · 已數理覆核 - [第 15560 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0060/) · R0030-15560 · 已數理覆核 - [第 15561 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0061/) · R0030-15561 · 已數理覆核 - [第 15562 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0062/) · R0030-15562 · 已數理覆核 - [第 15563 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0063/) · R0030-15563 · 已數理覆核 - [第 15564 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0064/) · R0030-15564 · 已數理覆核 - [第 15565 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0065/) · R0030-15565 · 已數理覆核 - [第 15566 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0066/) · R0030-15566 · 已數理覆核 - [第 15567 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0067/) · R0030-15567 · 已數理覆核 - [第 15568 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0068/) · R0030-15568 · 已數理覆核 - [第 15569 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0069/) · R0030-15569 · 已數理覆核 - [第 15570 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0070/) · R0030-15570 · 已數理覆核 - [第 15571 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0071/) · R0030-15571 · 已數理覆核 - [第 15572 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0072/) · R0030-15572 · 已數理覆核 - [第 15573 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0073/) · R0030-15573 · 已數理覆核 - [第 15574 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0074/) · R0030-15574 · 已數理覆核 - [第 15575 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0075/) · R0030-15575 · 已數理覆核 - [第 15576 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0001/) · R0030-15576 · 已數理覆核 - [第 15577 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0002/) · R0030-15577 · 已數理覆核 - [第 15578 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0003/) · R0030-15578 · 已數理覆核 - [第 15579 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0004/) · R0030-15579 · 已數理覆核 - [第 15580 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0005/) · R0030-15580 · 已數理覆核 - [第 15581 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0006/) · R0030-15581 · 已數理覆核 - [第 15582 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0007/) · R0030-15582 · 已數理覆核 - [第 15583 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0008/) · R0030-15583 · 已數理覆核 - [第 15584 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0009/) · R0030-15584 · 已數理覆核 - [第 15585 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0010/) · R0030-15585 · 已數理覆核 - [第 15586 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0011/) · R0030-15586 · 已數理覆核 - [第 15587 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0012/) · R0030-15587 · 已數理覆核 - [第 15588 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0013/) · R0030-15588 · 已數理覆核 - [第 15589 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0014/) · R0030-15589 · 已數理覆核 - [第 15590 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0015/) · R0030-15590 · 已數理覆核 - [第 15591 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0016/) · R0030-15591 · 已數理覆核 - [第 15592 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0017/) · R0030-15592 · 已數理覆核 - [第 15593 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0018/) · R0030-15593 · 已數理覆核 - [第 15594 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0019/) · R0030-15594 · 已數理覆核 - [第 15595 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0020/) · R0030-15595 · 已數理覆核 - [第 15596 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0021/) · R0030-15596 · 已數理覆核 - [第 15597 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0022/) · R0030-15597 · 已數理覆核 - [第 15598 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0023/) · R0030-15598 · 已數理覆核 - [第 15599 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0024/) · R0030-15599 · 已數理覆核 - [第 15600 題：二分圖](https://ocme.evemisslab.com/zh-Hant/questions/q-20261014-advance-20261031-r02-bipartite-graph-0025/) · R0030-15600 · 已數理覆核 原題庫保留原有候選與驗證標記；顯示與符號檢查不記作數學複審或獨立重算。 [完整出版目錄 JSON](https://ocme.evemisslab.com/data/question-derivations/publication.json) · [數理覆核索引 JSON](https://ocme.evemisslab.com/data/question-derivations/index.json)[上一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/77/) 第 78 / 180 [下一頁](https://ocme.evemisslab.com/zh-Hant/questions/page/79/)